All In Biotech

Free tool

FAERS Monitor: Exidine

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019127 or its brand name (Exidine, Chlorhexidine Gluconate). Reports on generic versions are filed under their own applications.

Reports

7,712

Serious

6,493

84% of reports

Hospitalization

3,782

Death reported

2,709

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue1,899
  • joint swelling1,721
  • rash1,694
  • hypersensitivity1,663
  • impaired healing1,631
  • folliculitis1,619
  • weight increased1,608
  • pain1,585
  • stomatitis1,569
  • arthralgia1,554
  • lower respiratory tract infection1,543
  • glossodynia1,530
  • blister1,515
  • off label use1,512
  • hand deformity1,506

Reports by year received

View as table
YearReports
200428
200519
200620
200738
200889
200995
2010151
2011160
2012163
201364
201483
2015131
2016235
2017268
2018297
2019310
2020402
2021676
2022602
2023507
20241,322
20251,535
2026517

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,046,447 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
folliculitisSignal1,619497.7474.4678,707
hand deformitySignal1,506353.6336.7468,725
glossodyniaSignal1,530200.0190.8282,367
impaired healingSignal1,631142.5136.3218,025
lower respiratory tract infectionSignal1,54395.891.5139,984
blisterSignal1,51575.672.2108,699
stomatitisSignal1,56972.469.2107,862
joint swellingSignal1,72139.437.863,873
hypersensitivitySignal1,66324.623.637,698
weight increasedSignal1,60819.718.928,653
rashSignal1,69410.610.215,034
arthralgiaSignal1,55410.29.813,140
painSignal1,5857.16.78,453
fatigueSignal1,8996.76.49,468
off label useSignal1,5124.74.54,607

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.